Did you know 90% of people who suffer out-of-hospital cardiac arrest die? Today Infor and the American Heart Association donated CPR Anytime kits to Penn Medicine. These kits provide CPR training materials for local patients and community members.

Using a genetically engineered pig liver, Penn Transplant Institute researchers successfully circulated a deceased donor's blood outside the body. A promising step towards a more effective "bridge" for critically ill patients awaiting liver transplants. spr.ly/6012riVYQ

A Penn Medicine research team announced the first successful completion of an experiment to circulate a recently deceased donor’s blood through a genetically engineered pig liver outside their body. inquirer.com/health/pig-liv…

Dozens of Penn Medicine experts in the fields of heart and lung transplant are in Prague this week to attend The ISHLT 2024. A sneak peek of Penn presenters and remarks by ISHLT President can be found in this media tool kit! Best of luck to all attending. pennmedicine.org/news/news-rele…

Check out a preview of the Penn Transplant Institute research that will be presented at the AmericanTransplantCongress in Philadelphia from June 1-5, covering topics such as living donor liver transplantation, interventions to improve early #transplant outcomes, and more. spr.ly/6016e5xhp

Here's a bit of transplant medicine history—you can all stop hounding me for it!—and a new study that raises questions about what kind of organ donation setup is actually best for transplant recipients. 🔓 statnews.com/2024/06/25/ind…

New research led by @emilyvailmd of Penn Anesthesia finds better survival rates for recipients of lungs from hospital-based donor care units compared to independent donor care units. spr.ly/6018gYC1A

New work from Mitch Lazar's laboratory highlighting a connection between liver clock, feeding and activity rhythms via hepatic vagal afferent signaling @MitchLazar1 science.org/doi/10.1126/sc…

Today the American Heart Association - Pennsylvania and Penn Medicine announced a three year movement called Team Up to Take Down High Blood Pressure. The goal? Lower the blood pressure of folks living in West & Southwest Philadelphia, where more than 1 in 3 people suffer from high blood pressure.

Last week, the AHA and Penn Medicine launched the “Team Up to Take Down High Blood Pressure” initiative with Family Practice and Counseling Network, Greater Philadelphia Health Action, Spectrum Health Services, Southwest CDC and Second Antioch Baptist Church.

Congratulations to @jennlewey and Lisa D. Levine, MD, MSCE on receiving The Patient-Centered Outcomes Research Institute funding for a study addressing postpartum hypertension. This research compares "low-touch" and "high-touch" blood pressure management programs. Penn Medicine OBGYN Department spr.ly/6013t41fU

'I'm a heart transplant recipient. I'm disabled, and I beat cancer': Young woman shares health struggles, how she wants to help others Grace Griffaton reports. wfmz.com/news/area/lehi…

Thank you to the 76ers Fans for recognizing our #TAVR leadership team! The Penn TAVR Program is one of the largest & highest-rated programs of its kind, achieving the highest distinction of 3 ⭐s by The Society of Thoracic Surgeons / ACC TVT registry. Penn Medicine Nimesh Desai MD PhD Howard Herrmann

A 76-year-old grandfather brushed off an odd chest flutter—then learned his aorta was about to burst. With his grandson’s future on the line, Penn Medicine’s Aortic team saved his life. spr.ly/6018LeEZY

In April, Penn Transplant Institute performed a record-breaking 67 transplants. No better way to mark #DonateLifeMonth than by saving more lives in one month than ever before. Consider becoming an organ donor and give the gift of life: spr.ly/6018N8a9E

For the first time in 45 years, a new subtype of Castleman disease has been identified, allowing patients to receive the right treatment for their condition ft. David Fajgenbaum, MD (Penn Medicine) & Joshua Brandstadter MD PhD (Penn Medicine - Abramson Cancer Center) CDCN tinyurl.com/52mjd9az

CHOP & Penn Medicine have delivered the first-ever personalized gene editing therapy for a patient with CPS1 deficiency, marking a major milestone in the application of CRISPR-based treatments. Learn more about KJ & the future of personalized medicine: ms.spr.ly/6015SZLAx.

Breaking News: A baby with a rare disorder made medical history by receiving the first custom gene-editing treatment. The technique used has the potential to help people with thousands of other uncommon genetic diseases. nyti.ms/4j3xGs8

Congratulations to Scott Halpern (PAIR Center), Jason Christie (PennPulmonaryFellowship) & Michael Harhay (Dept. of Biostatistics, Epidemiology & Informatics) on being named American Thoracic Society (ATS) 2025 Respiratory Health Awardees! tinyurl.com/357uckvh

Catch David Fajgenbaum, MD on FOX 29 this morning! He’s talking about his mission to repurpose already approved drugs… and the major motion picture about his life!